NCT04987229Phase 3Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Study sponsor: Alkermes, Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-09Estimated
Enrollment · participants236Estimated
Source updated2026-08-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.